Molecular characterization of breast cancer needle core biopsy specimens by the 21-gene Breast Recurrence Score test.

Jakubowski, Debbie M; Bailey, Helen; Abran, John; Blacklock, Andrea; Ciau, Nancy; Mies, Carolyn; Tan, Vivian; Young, Rebekah; Lau, Anna; Baehner, Frederick L

Jakubowski, Debbie M; Bailey, Helen; Abran, John; Blacklock, Andrea; Ciau, Nancy; Mies, Carolyn; Tan, Vivian; Young, Rebekah; Lau, Anna; Baehner, Frederick L.

Afiliación

Jakubowski DM; Exact Sciences Corporation, Redwood City, California.
Bailey H; Exact Sciences Corporation, Redwood City, California.
Abran J; Exact Sciences Corporation, Redwood City, California.
Blacklock A; Exact Sciences Corporation, Redwood City, California.
Ciau N; Exact Sciences Corporation, Redwood City, California.
Mies C; Exact Sciences Corporation, Redwood City, California.
Tan V; Exact Sciences Corporation, Redwood City, California.
Young R; Exact Sciences Corporation, Redwood City, California.
Lau A; Exact Sciences Corporation, Redwood City, California.
Baehner FL; Exact Sciences Corporation, Redwood City, California.

J Surg Oncol ; 122(4): 611-618, 2020 Sep.

Article en En | MEDLINE | ID: mdl-32497318

Palabras clave

COVID-19 pandemic; Oncotype DX; Recurrence Score result; core needle biopsy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: J Surg Oncol Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google